1. Product Overview
NPP100 is presented as an OmegaLab-associated injectable anabolic-androgenic steroid preparation containing nandrolone phenylpropionate.
The supplied Roidsdeal product title identifies the compound as nandrolone phenylpropionate with a declared concentration of 100 mg/mL.
The Finest Gears long description additionally identifies a 10 mL vial and lists Omega Lab as the manufacturer.
If the declared concentration and 10 mL volume are both accurate, the calculated total nandrolone phenylpropionate content would be 1,000 mg (1 g) per vial.
However, the 10 mL package size is not independently supported by the Roidsdeal title or descriptions.
Nandrolone phenylpropionate is an esterified form of nandrolone, a synthetic anabolic-androgenic steroid structurally related to testosterone.
The phenylpropionate ester influences the compound’s release characteristics and is generally associated with a shorter duration of action than nandrolone decanoate.
Nandrolone compounds have a history of medical investigation and use in selected clinical settings.
However, historical medical applications do not establish that OmegaLab NPP100 is an authorized pharmaceutical preparation.
The supplied Roidsdeal short and long descriptions are empty, and the Finest Gears short-description field is also empty.
Consequently, most formulation and packaging details beyond the product title originate from the Finest Gears long description.
No independent manufacturer documentation, laboratory analysis, or regulatory authorization has been supplied.
2. What Is NPP100?
NPP100 is the commercial product name associated with a nandrolone phenylpropionate preparation.
Nandrolone is a synthetic anabolic-androgenic steroid also known as 19-nortestosterone.
Its chemical structure differs from testosterone through the absence of a methyl group at the 19-position.
Nandrolone phenylpropionate consists of nandrolone chemically linked to a phenylpropionate ester.
The ester influences the compound’s physicochemical properties and release characteristics.
Following ester hydrolysis, nandrolone becomes available to interact with androgen receptors in hormone-responsive tissues.
Nandrolone phenylpropionate differs from nandrolone decanoate, another esterified form of nandrolone.
Although both compounds ultimately release nandrolone, their ester structures influence their pharmacokinetic characteristics.
The phenylpropionate ester is generally associated with a shorter release profile than the decanoate ester in comparable injectable formulations.
However, the exact absorption and release characteristics of OmegaLab NPP100 cannot be established without formulation-specific information.
Nandrolone phenylpropionate belongs to the anabolic-androgenic steroid class, not the selective androgen receptor modulator (SARM) class.
Although nandrolone may exhibit relatively lower androgenic activity than testosterone in certain experimental contexts, this does not mean it is free from androgen-related adverse effects.
The actual ingredient concentration, excipients, manufacturing quality, and sterility of NPP100 remain unverified.
3. How Does Nandrolone Phenylpropionate Work?
Nandrolone phenylpropionate produces pharmacological effects associated with nandrolone following ester hydrolysis.
Ester Hydrolysis
Nandrolone phenylpropionate is an esterified derivative of nandrolone.
The phenylpropionate ester influences release characteristics in appropriately formulated preparations.
Following ester cleavage, nandrolone becomes available to interact with androgen-responsive biological systems.
Androgen Receptor Activation
Nandrolone acts as an androgen receptor agonist.
Androgen receptors influence gene expression and participate in biological processes involving muscle, bone, reproductive tissues, and other hormone-responsive systems.
Protein Metabolism
Experimental and historical clinical research has examined nandrolone’s effects on protein metabolism and nitrogen balance.
These biological effects do not establish that nonmedical anabolic steroid use is safe or appropriate.
Phenylpropionate Ester Characteristics
The phenylpropionate ester is generally associated with shorter release characteristics than nandrolone decanoate.
However, no product-specific pharmacokinetic studies for OmegaLab NPP100 have been supplied.
Hematological Effects
Nandrolone may influence erythropoiesis, the process responsible for red blood cell production.
Excessive hematological changes can contribute to medical complications.
Aromatization and Progestogenic Activity
Nandrolone can undergo limited aromatization and exhibits progestogenic activity.
These characteristics may contribute to endocrine and reproductive effects.
Endocrine Feedback
Exogenous anabolic-androgenic steroids can suppress hypothalamic-pituitary-gonadal axis activity.
This may reduce endogenous testosterone production and impair reproductive function.
Cardiovascular and Metabolic Effects
Nandrolone exposure can adversely influence lipid concentrations and other cardiovascular risk factors.
The exact effects associated with this commercial preparation have not been independently established.
4. Medical Uses & Clinical Information
Nandrolone compounds have a history of medical investigation and use in selected clinical settings.
However, historical use does not establish current regulatory approval for OmegaLab NPP100.
Historical Medical Applications
Certain nandrolone preparations have historically been used or investigated in conditions involving anemia, tissue wasting, and other disorders where anabolic effects were considered clinically relevant.
The precise indications and authorization status vary by compound, formulation, country, and time period.
Nandrolone Phenylpropionate Preparations
Nandrolone phenylpropionate has appeared in historical pharmaceutical formulations in certain international markets.
Its regulatory status should not be assumed identical across countries.
Comparison with Nandrolone Decanoate
Nandrolone phenylpropionate and nandrolone decanoate contain different ester groups.
The medical history or regulatory authorization of one ester does not automatically establish authorization for another.
Androgen Receptor Research
Nandrolone has been investigated for its interaction with androgen receptors.
These studies contribute to scientific understanding of synthetic androgen activity.
Muscle and Protein Metabolism
Research has examined nandrolone in relation to protein metabolism and tissue physiology.
These findings should not be interpreted as evidence supporting unsupervised performance enhancement.
Bone and Hematological Research
Nandrolone compounds have been studied in relation to bone physiology and erythropoiesis.
Potential physiological effects must be considered alongside endocrine, cardiovascular, and other safety concerns.
Reproductive Endocrinology
Exogenous nandrolone can suppress normal reproductive hormone signaling.
Reduced endogenous testosterone production and impaired fertility are important concerns.
Cardiovascular Considerations
Anabolic-androgenic steroid exposure may adversely affect cholesterol concentrations, blood pressure, and cardiovascular health.
Individual risks depend on exposure, underlying health conditions, and other factors.
Athletic Performance Claims
Nandrolone is sometimes discussed in bodybuilding and athletic performance contexts.
However, performance enhancement is not an established safe medical indication.
Nandrolone and its esters are prohibited in competitive sport under WADA regulations.
Clinical Limitations
No verified product-specific clinical trials, FDA approval documentation, or official prescribing information have been supplied for OmegaLab NPP100.
Research involving other nandrolone preparations should not be interpreted as proof of the safety or effectiveness of this commercial product.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | NPP100 / NPP 100 |
| Brand Association | OmegaLab — Unverified |
| Listed Manufacturer | Omega Lab — Finest Gears Claim |
| Active Ingredient | Nandrolone Phenylpropionate |
| Chemical Classification | Esterified 19-Nortestosterone |
| Pharmacological Classification | Anabolic-Androgenic Steroid |
| Ester Type | Phenylpropionate |
| Declared Concentration | 100 mg/mL |
| Product Form | Injectable Preparation |
| Package Size | 10 mL Vial — Finest Gears Claim |
| Calculated Total Ester Content | 1,000 mg, Conditional on 10 mL Volume |
| Free Nandrolone Equivalent | Not Established |
| Release Characteristics | Generally Shorter-Acting Than Nandrolone Decanoate |
| Carrier Oil / Vehicle | Not Specified |
| Solvents and Preservatives | Not Specified |
| Other Excipients | Not Specified |
| US Controlled Substance Status | Schedule III |
| WADA Status | Prohibited |
| Product-Specific FDA Approval | Not Established |
| Batch-Specific COA | Not Provided |
| Sterility Testing | Not Provided |
| Endotoxin Testing | Not Provided |
| Actual Ingredient Concentration | Not Independently Verified |
| Manufacturing Quality | Not Independently Verified |
Source Documentation
The Roidsdeal product title identifies nandrolone phenylpropionate at 100 mg/mL and associates the product with OmegaLab.
The Roidsdeal short-description and long-description fields contain no additional information.
The Finest Gears short-description field is also empty.
The Finest Gears long description supplies the 10 mL vial specification and additional manufacturer information.
Therefore, the 10 mL package size and calculated 1,000 mg total should be treated as provisional rather than independently confirmed product specifications.
No authenticated manufacturer label, batch-specific laboratory report, sterility documentation, or complete formulation details have been supplied.
6. Administration & Medical Supervision
NPP100 is described in the Finest Gears long description as an injectable nandrolone phenylpropionate preparation.
Nandrolone is a pharmacologically active synthetic anabolic-androgenic steroid.
The supplied documentation does not establish an authorized human dosing regimen for this specific product.
The declared concentration of 100 mg/mL identifies the claimed amount of nandrolone phenylpropionate per milliliter.
It does not represent a recommended or medically appropriate dose.
No injection procedure, administration schedule, bodybuilding cycle, stacking protocol, or performance-enhancement regimen is supported by the supplied information.
Medical evaluation of anabolic-androgenic steroid exposure may involve blood pressure assessment, lipid measurements, complete blood counts, liver-related laboratory tests, and endocrine evaluation.
Nandrolone exposure can suppress endogenous reproductive hormone production and impair fertility.
The actual concentration, sterility, and pharmaceutical quality of OmegaLab NPP100 remain unverified.
The product should not be assumed suitable for human administration based solely on the supplied descriptions.
7. Possible Side Effects & Safety Limitations
Nandrolone phenylpropionate can produce adverse effects associated with anabolic-androgenic steroid exposure.
Endocrine and Reproductive Effects
Potential adverse effects include:
- Suppression of endogenous testosterone production
- Reduced sperm production
- Reduced fertility
- Testicular atrophy
- Menstrual disturbances
- Changes in libido
- Gynecomastia or breast tenderness
Cardiovascular and Metabolic Effects
Potential complications include:
- Adverse cholesterol changes
- Reduced HDL cholesterol
- Elevated blood pressure
- Fluid retention
- Cardiovascular complications
Androgenic Effects
Potential androgen-related effects include:
- Acne
- Oily skin
- Hair loss in genetically susceptible individuals
- Increased facial or body hair
- Virilization in females
Some androgenic changes may be irreversible.
Psychological and Behavioral Effects
Anabolic-androgenic steroid exposure may be associated with mood changes, irritability, sleep disturbances, and other behavioral effects.
Hematological and Liver-Related Concerns
Anabolic-androgenic steroids may influence blood cell production and liver-related laboratory parameters.
The clinical significance depends on the compound, exposure, and individual circumstances.
Injectable Formulation Risks
Unverified injectable products may introduce additional risks involving:
- Microbial contamination
- Injection-site infection
- Tissue irritation or injury
- Incorrect ingredient concentrations
- Undisclosed excipients
- Sterility failures
Serious Symptoms
Chest pain, unexplained shortness of breath, sudden neurological symptoms, or severe injection-site inflammation require urgent medical evaluation.
No product-specific adverse-event frequency or established safety profile has been supplied for OmegaLab NPP100.
8. Warnings & Precautions
Nandrolone phenylpropionate is a synthetic anabolic-androgenic steroid with significant endocrine, reproductive, and cardiovascular considerations.
In the United States, nandrolone is classified as a Schedule III controlled anabolic steroid.
Exogenous nandrolone exposure can suppress normal reproductive hormone production and negatively affect fertility.
Individuals with cardiovascular disease, hypertension, abnormal lipid concentrations, liver disease, or endocrine disorders may face additional complications.
Nandrolone’s progestogenic activity and limited aromatization can contribute to hormone-related adverse effects.
Exposure during pregnancy may cause developmental harm and virilization.
Use in children and adolescents presents additional concerns because androgenic compounds may interfere with normal growth and skeletal maturation.
Combining nandrolone with other anabolic steroids or hormone-modifying substances may increase adverse-effect risks.
Nandrolone and its esters are prohibited in competitive sport under WADA regulations.
The supplied descriptions do not establish that OmegaLab NPP100 is an FDA-approved medication or an authorized pharmaceutical preparation.
Product identity, concentration, formulation, sterility, manufacturing quality, and regulatory authorization require independent verification.
9. Storage & Handling
NPP100 is described in the Finest Gears long description as a 10 mL injectable product.
However, authenticated manufacturer storage temperatures, stability data, sterility specifications, and expiration requirements have not been supplied.
Storage conditions depend on the formulation, carrier vehicle, excipients, container closure system, and manufacturing process.
These details remain unknown.
Storage should follow authentic manufacturer documentation when available.
The product should remain in its original, clearly identified packaging.
Avoid environmental conditions that may compromise formulation stability or packaging integrity.
Keep the product away from children and unauthorized access.
A sealed vial does not independently establish sterility or suitability for human administration.
Products with damaged packaging, uncertain labeling, or unverified storage history should not be assumed safe for use.
No validated product-specific in-use stability information has been supplied.
10. Frequently Asked Questions (FAQs)
What is the active ingredient in NPP100?
NPP100 is identified as containing nandrolone phenylpropionate, an esterified synthetic anabolic-androgenic steroid.
What is the declared concentration?
The Roidsdeal title and Finest Gears long description identify a concentration of 100 mg/mL. Actual potency has not been independently verified.
What is the package size?
The Finest Gears long description specifies a 10 mL vial. This package size is not independently confirmed by the Roidsdeal product information.
How does nandrolone phenylpropionate differ from nandrolone decanoate?
Both compounds contain nandrolone attached to different ester groups. The phenylpropionate ester generally has a shorter release profile than the decanoate ester in comparable formulations.
Is NPP100 an FDA-approved sports supplement?
No. Nandrolone is a controlled anabolic-androgenic steroid, not a conventional nutritional supplement. No product-specific FDA approval has been established for OmegaLab NPP100.
11. Conclusion & Medical Disclaimer
NPP100 is presented as an OmegaLab-associated injectable nandrolone phenylpropionate preparation.
The Roidsdeal product title identifies a declared concentration of 100 mg/mL.
The supplied Finest Gears long description additionally identifies a 10 mL vial.
If both specifications are correct, the calculated total nandrolone phenylpropionate content is 1,000 mg per vial.
However, the package volume, actual concentration, manufacturer identity, formulation, sterility, and manufacturing quality have not been independently established.
Nandrolone phenylpropionate is an esterified synthetic anabolic-androgenic steroid with a history of medical investigation and use in certain settings.
Historical medical applications do not establish regulatory authorization for this specific OmegaLab product.
No authenticated manufacturer documentation, batch-specific analytical report, or product-specific clinical evidence has been supplied.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, injection guidance, dosage recommendations, or a recommendation for nonmedical anabolic steroid use, bodybuilding, athletic performance enhancement, or treatment of any medical condition.




Reviews
There are no reviews yet.